Articles by: Geisel Communications

Store-Based Clinics May Not Hold Down Costs After All – The Boston Globe

Read article – Quotes Elliott Fisher, director of The Dartmouth Institute for Health Policy and Clinical Practice and professor of medicine and community and family medicine, about a recent study where researchers found that retail clinics—clinics inside drugstores and department stores—increase medical spending by attracting people who otherwise would have stayed home.

Six Signs the Next 10 Yrs. for Alcohol Biz Will Be Like the Last 20 for Tobacco – Examiner

Read article – James Sargent, the Scott M. and Lisa G. Stuart Professor of Pediatric Oncology and professor of pediatrics and of community and family medicine, is quoted about how more is done to curtail junk-food advertising aimed at young people than to prevent them from viewing alcohol ads. “There’s very strong evidence that underage drinkers are not only exposed to the television advertising, but they also assimilate the messages,” says Sargent. “That process moves them forward in their drinking behavior.”

Document Claims Drug Makers Deceived a Top Medical Journal – The New York Times

Read article – Lisa Schwartz, professor of medicine, community and family medicine, and of The Dartmouth Institute for Health Policy and Clinical Practice, is quoted about how two pharmaceutical companies—Johnson & Johnson and Bayer—and researchers from Duke University omitted critical laboratory data from a letter published in The New England Journal of Medicine in an effort to protect their blockbuster anticlotting drug. “It just feels like it’s a real ethical breach,” says Schwartz. “If you know the direct answer to this question, then how can you not provide it to be able to give insight?”

New Study Claims Female Viagra Marginally Effective and Has Multiple Side Effects – International Business Times

Read article – Continued coverage of comments by Lisa Schwartz and Steven Woloshin, both professors of medicine, community and family medicine, and of The Dartmouth Institute for Health Policy and Clinical Practice, from an editorial about their concerns regarding the drug  flibanserin, which was rejected twice by the FDA after findings of weak benefit and potentially serious side effects.

Students Take on Leadership Roles in the Classroom at Manchester’s Gossler Park Elementary School – New Hampshire Union Leader

Read article – An article that mentions The Dartmouth Institute for Health Policy and Clinical Practice is one of the many institutions that fund a program at Gossler Park Elementary School in Manchester, N.H., called The Leader in Me, a program based on the book 7 Habits of Highly Effective People by Steven Covey, as part of a Neighborhood Health Improvement Strategy initiated this fall.

Dr. Phil Is Not a Medical Doctor. But he Is Now a Paid Spokesperson for a Diabetes Drug – Vox

Read Article –  Steven Woloshin, professor of medicine, Community and Family Medicine, and of The Dartmouth Institute for Health Policy and Clinical Practice, is quoted about how TV personality Phil McGraw, better known as Dr. Phil, has been hired by the drugmaker AstraZeneca as a paid spokesperson and it presents conflict-of-interest problems. “These campaigns create a blurriness between marketing and public health messages,” says Woloshin. “People tend to view them with less skepticism, particularly when there is a trusted celebrity spokesperson.”

Dartmouth-Hitchcock Launches ‘Living Laboratory’ to Drive Health Care Innovation – Vermont Biz

Read article – Quotes Stephen Bartels, professor of psychiatry, community and family medicine, and of The Dartmouth Institute for Health Policy and Clinical Practice, about a new population health initiative at Dartmouth-Hitchcock Medical Center (D-H) that is developing innovative ways of delivering care, and accelerating the process for implementing those innovations, in a “collaborative living laboratory” known as the Population Health Collaboratory.